Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crovalimab vs Eculizumab in PNH (COMMODORE 2)
NCT04434092Phase 3Active, not recruiting
- Sponsor
- Roche
- Start
- Oct 2020
- Primary completion
- Nov 2022
- Countries
- 23
01
Overview
A Phase 3 trial of crovalimab in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Roche. Started Oct 2020; status: active, not recruiting.
02
Drugs
crovalimab
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT04434092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04434092.